A proactive strategy that promotes U.S. pharmaceutical manufacturing is a crucial pillar within a resilient and diversified ...

Drug shortages in US health care facilities have reached an all-time high, with 323 active shortages in early 2024, significantly impacting pediatric settings. Hospitals spend 20 million hours ...

After Trump's announcement, Commerce Secretary Howard Lutnick told CNBC that details on pharmaceutical tariffs would come at ...

US import tariffs on Indian pharmaceuticals could lead to a 200% price increase for US consumers. The impact on Indian pharma ...

Indian pharmaceutical companies are expected to sustain their growth momentum into FY26, supported by strong performance in the US generics market, ongoing drug shortages, and robust demand in India’s ...

The US generic drug market size reached USD 93.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach ...

Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both ...